Krebs Biochemicals and Industries Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The promoters and persons acting in concert of Krebs Biochemicals and Industries have filed their annual declaration under SEBI's Takeover Regulations. They have confirmed that they did not create any encumbrance (such as pledge, lien, or charge) on the shares they hold in the company during the financial year (April 2024 to March 2025). The declaration was signed by six promoter-group members: Dr. R.T. Ravi, Mrs. Hemalata Ravi, Mr. Avinash Ravi, Mr. Aditya Ravi, and Mr. Ajay Ravi. This is a routine yearly compliance filing required under Regulation 31(4) of the SEBI Takeover Regulations, 2011.
This is a routine negative declaration and is neutral for shareholders. It simply confirms that promoters did not pledge any of their holdings during the year, which is mildly reassuring as it indicates no immediate liquidity stress on the promoter side.